Similar articles

• [Coronary flow and and cardiac output of waking dogs during physical exertion under beta-receptor blockade].

  Kucharczyk M, Holtz J, Stoian D, Bassenge E. Kucharczyk M, et al. Naunyn Schmiedebergs Arch Pharmakol. 1970;266(4):384-5. Naunyn Schmiedebergs Arch Pharmakol. 1970. PMID: 4397504 German. No abstract available.
• Pharmacological aspects of oxprenolol.

  Brunner H, Hedwall PR, Maier R, Meier M. Brunner H, et al. Postgrad Med J. 1970 Nov:Suppl:5-14. Postgrad Med J. 1970. PMID: 4395460 No abstract available.
• Circulatory effects of oxprenolol, a new beta-adrenergic blocking agent.

  Reale A, Motolese M, Imhof P. Reale A, et al. Int Z Klin Pharmakol Ther Toxikol. 1970 Jul;3(3):288-93. Int Z Klin Pharmakol Ther Toxikol. 1970. PMID: 4394124 Clinical Trial. No abstract available.
• [Beta adrenergic drugs in arterial hypertension].

  Gysling E. Gysling E. Union Med Can. 1972 Jul;101(7):1336-41. Union Med Can. 1972. PMID: 4402882 Review. French. No abstract available.
• Regional myocardial blood flow, ischemia and antianginal drugs.

  Becker L, Pitt B. Becker L, et al. Ann Clin Res. 1971 Dec;3(6):353-61. Ann Clin Res. 1971. PMID: 4400461 Review. No abstract available.